Stock Events

Stock Events

Denali Therapeutics (4DN.F) Q3 2024 Earnings

1AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.79

-0.71

-0.63

-0.55

Details

Expected EPS

-0.65100943875

Actual EPS

-0.5467825

Surprise EPS

0.1

Surprise Percent

+16.01%

Description

Denali Therapeutics (4DN.F) has reported earnings of -0.5467825 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.